DOCSLIB.ORG

Clinical Practice Newsletters

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Clinical Practice Newsletters European Society of Hypertension Clinical Practice Newsletters Update 2011 Gdańsk 2011 Managing editor: Joanna Gajkowska Copyright © by 2011 European Society of Hypertension Publisher: VM Media sp. z o.o., VM Group sp.k. ul. Świętokrzyska 73, 80–180 Gdańsk tel.: +48 58 320 94 94, fax: +48 58 320 94 60 www.viamedica.pl e-mail: [email protected] All rights reserved. No part of this work can be reproduced or transferred by mechanical, magnetic or electronic means, including photocopying, recording, or transfer to information storage systems, without the written approval of the Publisher. Althought all efforts have been made to ensure that drug doses and other information have been correctly presented in this publication, full responsibility for such information and prescription resides with the practising physician. Neither the publisher, nor the authors are responsible for any error or concequences that may be arise through the use oh the information published In this book. All products mentioned in this book should be used in accordance with the information provided by the manufactures. Gdańsk 2011 1st edition ISBN 978–83–7599–301–1 Table of Contents Treatment of hypertension in patients with type 2 diabetes mellitus Peter M. Nilsson, Renata Cífková, Sverre E. Kjeldsen ..................................................................................................... 1 Hypertension in pregnancy: recommendations for diagnosis and treatment Renata Cífková .............................................................................................................................................................. 3 How well is hypertension controlled in Europe? Serap Erdine.................................................................................................................................................................. 5 Hypertension in chronic renal failure Jose L. Rodicio, Jose M. Alcazar ..................................................................................................................................... 7 How to handle renovascular hypertension? Jose M. Alcazar, Jose L. Rodicio ..................................................................................................................................... 9 Isolated systolic hypertension: cardiovascular risk and treatment benefits Csaba Farsang, Peter Sleight ....................................................................................................................................... 11 Patient adherence and pharmacological treatment of arterial hypertension Menno Pruijm, Marie-Paule Schneider, Michel Burnier ................................................................................................ 13 Cyclosporin-induced hypertension Renata Cífková, Hermann Haller.................................................................................................................................. 15 Hypertension and left ventricular hypertrophy Enrico Agabiti Rosei, Maria Lorenza Muiesan .............................................................................................................. 17 Assessment of preclinical target organ damage in hypertension: carotid intima-media thickness and plaque Enrico Agabiti Rosei, Maria Lorenza Muiesan .............................................................................................................. 19 Home blood pressure monitoring Gianfranco Parati, Grzegorz Bilo, Sverre E. Kjeldsen, Giuseppe Mancia ....................................................................... 21 Hypertension in children and adolescents Empar Lurbe ............................................................................................................................................................... 23 Hypertension and coronary heart disease Jean-Philippe Baguet, Gilles Barone-Rochette, Jean-Michel Mallion ............................................................................. 25 Resistant hypertension Serap Erdine, Eren Arslan, Antonio Coca ..................................................................................................................... 27 Microalbuminuria in type-1 diabetes mellitus Josep Redon, Jose Luis Rodicio .................................................................................................................................... 29 Interactions between antihypertensive agents and other drugs Peter A. van Zwieten, Sandor Alfoldi, Csaba Farsang .................................................................................................. 31 Beneficial combinations of two or more antihypertensive agents Peter A. van Zwieten, Sandor Alfoldi, Csaba Farsang .................................................................................................. 33 The clinical value of ambulatory blood pressure monitoring Jean-Michel Mallion, Jean-Philippe Baguet, Gianfranco Parati, Giuseppe Mancia ........................................................ 35 High blood pressure, smoking and cardiovascular risk Helios Pardell† José L. Rodicio, Dagmara Hering, Anna Szyndler, Krzysztof Narkiewicz ............................................. 37 Treatment of hypertension in dialysed patients István Kiss, Csaba Farsang, Jose L. Rodicio .................................................................................................................. 39 High blood pressure, alcohol, and cardiovascular risk Ramon Estruch, Antonio Coca, José L. Rodicio ............................................................................................................ 43 Exercise and hypertension Athanasios J. Manolis, Andreas Pittaras, Costas Tsioufis, Peter Kokkinos .................................................................... 45 Hypertension and arrhythmia Jean-Philippe Baguet, Serap Erdine, Jean-Michel Mallion ............................................................................................ 47 Hypertension and obstructive sleep apnoea Jean-Philippe Baguet, Krzysztof Narkiewicz, Jean-Louis Pépin, Patrick Levy, Renaud Tamisier, Anne-Laure Borel, Gianfranco Parati, Jean-Michel Mallion .......................................................................................... 49 Control of hypertension in patients with peripheral artery disease Denis L. Clement ......................................................................................................................................................... 51 Prevention of type 2 diabetes mellitus with antihypertensive drugs Peter M. Nilsson, Renata Cífková, Sverre E. Kjeldsen, Giuseppe Mancia ....................................................................... 53 Treatment of hypertensive urgencies and emergencies Enrico Agabiti Rosei, Massimo Salvetti, Csaba Farsang ............................................................................................... 55 Treatment of high blood pressure in the elderly Sverre E. Kjeldsen, Aud-E. Stenehjem, Ingrid Os, Thomas Hedner, Gordon T. McInnes................................................ 57 Hypertension and heart failure Enrico Agabiti Rosei, Maria Lorenza Muiesan, Wolfang Kiowski .................................................................................. 59 Hypertension and macrovascular disease Stéphane Laurent ........................................................................................................................................................ 61 Sexual dysfunction in hypertension Athanasios J. Manolis, Michael Doumas, Margus Viigimaa, Krzysztof Narkiewicz ....................................................... 63 Discovering the genetic determinants of hypertension Sandosh Padmanabhan, Olle Melander, Claire Hastie, Anna F. Dominiczak ................................................................ 65 The microcirculation and the haemodynamics of hypertension Harry A.J. Struijker-Boudier, Enrico Agabiti Rosei ........................................................................................................ 67 Statins and hypertension Renata Cífková, Peter M. Nilsson ................................................................................................................................. 69 Microalbuminuria in essential hypertension Josep Redon, Fernando Martinez, Jose M. Pascual ...................................................................................................... 71 Hypertension in athletes Robert H. Fagard ......................................................................................................................................................... 73 Metabolic syndrome in hypertension Josep Redon ................................................................................................................................................................ 75 Hypertension and stroke Cristina Sierra, Antonio Coca ...................................................................................................................................... 77 Dietary sodium intake and hypertension Michel Burnier, Murielle Bochud, Roland Schmieder ................................................................................................... 79 Hypertensive retinopathy Roland E. Schmieder ................................................................................................................................................... 81 Hypertension and atrial fibrillation, with an emphasis on prevention Sverre E. Kjeldsen, Tonje A. Aksnes, Roland E. Schmieder ..........................................................................................
Load more

Recommended publications
  • GAIN-Tokyo-Workshop-Report.Pdf
    September 12th, 2018 Global AI Narratives – Tokyo Workshop 01 Table of Contents Summary ・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・2 Welcome remarks ・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・5 ・Dr Stephen Cave, Executive Director, CFI, University of Cambridge ・Professor Emeritus Shuji Hashimoto, Vice President, Waseda University Session 1: UK AI Narratives ・・・・・・・・・・・・・・・・・・・・・・・・・・・・ 7 ・Dr Kanta Dihal, PI ‘Global AI Narratives’ CFI, University of Cambridge ・Dr Stephen Cave, Executive Director, CFI, University of Cambridge ・Dr Sarah Dillon, University Lecturer in Literature and Film and co-PI ‘AI Narratives’ at CFI, University of Cambridge Session 2: JAPAN AI Narratives ・・・・・・・・・・・・・・・・・・・・・・・・・・9 ・Professor Toshie Takahashi, Faculty of Letters, Arts and Sciences, Waseda University ・Mr Masayoshi Sakai, visiting research fellow, GLOCOM(Center for Global Communications, International University of Japan) ・Professor Osamu Sakura, the Interfaculty Initiative in Information Studies, University of Tokyo, and RIKEN Center for Advanced Intelligence Project (AIP) ・Dr Kentaro Watanabe, Planning Offcer, Research Planning Offce for Artifcial Intelligence, Department of Information Technology and Human Factors, National Institute of Advanced Industrial Science and Technology (AIST) Session 3: KOREA AI Narratives ・・・・・・・・・・・・・・・・・・・・・・・・・ ・13 ・Professor Kyung Sin Park, Korea University Law School, Director, Open Net Korea ・Professor Chihyoung Jeon, KAIST ・Professor So-Young Kim, Head of the Graduate School of Science & Technology Policy, KAIST ・Dr Kyoungmi Oh, Seoul National University of Science and Technology Session 4: Interactive Exercise on Global AI Narratives “Cultural Differences between East and West about AI Imaginings” ・・・・・・・・ ・16 Closing Remarks ・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・ ・20 Professor Hironori Kasahara, Waseda University, IEEE Computer Society 2018 President Speakers and Participants ・・・・・・・・・・・・・・・・・・・・・・・・・・・ ・22 September 12th, 2018 Global AI Narratives – Tokyo Workshop September 12th, 2018 Global AI Narratives – Tokyo Workshop 02 Summary Dr. Stephen Cave & Dr.
    [Show full text]
  • Hypertension – Adult – Clinical Practice Guideline
    Hypertension – Adult – Clinical Practice Guideline Table of Contents EXECUTIVE SUMMARY ........................................................................................................... 3 SCOPE ...................................................................................................................................... 4 METHODOLOGY ...................................................................................................................... 5 INTRODUCTION ....................................................................................................................... 5 RECOMMENDATIONS .............................................................................................................. 5 Establish the Diagnosis ........................................................................................... 5 Patient Evaluation ................................................................................................... 7 Treatment Goals ..................................................................................................... 7 Lifestyle Modifications ............................................................................................. 8 Table 4 – Lifestyle Modifications ........................................................................ 9 Medication Treatment............................................................................................ 11 Figure 1 - Initiation and Titration of Antihypertensive Medication ..................... 13 Table 7 - Antihypertensive
    [Show full text]
  • Tina GARABEDIAN ARM Simon PROULX-SENECAL
    ICE DANCE Date of birth: 13.06.1997 Tina GARABEDIAN Place of birth: Montreal CAN Height: 163 cm ARM Home town: Montreal CAN Profession: student Hobbies: swimming, music Start sk. / Club: 2002 / Armenia Internet / Social Media contact (couple): Facebook: Ice Dance Armenia.com Former Partners Alexandre Laliberte Date of birth: 06.12.1991 Simon PROULX-SENECAL Place of birth: Lasalle CAN Height: 186 cm ARM Home town: Montreal CAN Profession: student Hobbies: swimming, music, biking Start sk. / Club: 1998 / Armenia Internet / Social Media contact (couple): Facebook: Ice Dance Armenia.com Former Partners Melissandre Dumas Coach: Elise Hamel, Shawn Winter Choreographer: Former Coach: Shae Zukiwsky Practice low season: 25 h / week Montreal/CAN Practice high season: 25 h / week Montreal/CAN Music Short Program / Short Dance as of season 2016/2017 Blues Swing Music Free Skating / Free Dance as of season 2016/2017 Pearl Harbour (soundtrack) by Hans Zimmer Personal Best Total Score 139.28 07.12.2016 ISU CS Golden Spin 2016 Personal Best Score Short Dance 53.94 18.11.2016 ISU CS Warsaw Cup 2016 Personal Best Score Free Dance 87.54 07.12.2016 ISU CS Golden Spin 2016 09/10 10/11 11/12 12/13 13/14 14/15 15/16 16/17 Olympic Games World Champ. 27. European Champ. 18. 19. Four Continents World Juniors 16.(1) National Champ. 11.J(3) 11.J(3) 15.J(2) 9.J(1) / 11.S(4) 1.S(1) / 12.S(4) 1.S S=Senior; J=Junior; N=Novice International Competition Year Place Internation Competition Year Place ISU CS Ice Challenge 2015 Graz 2015 6.
    [Show full text]
  • Norges Skøyteforbund Årbok 2015–2017
    Norges Skøyteforbund Årbok 2015–2017 Versjon 2 – 30.05.2017 ©Norges Skøyteforbund 2017 Redaktør: Halvor Lauvstad Historikk/resultater: Svenn Erik Ødegård Trond Eng Bjørg Ellen Ringdal Tilrettelegging: Halvor Lauvstad Distribusjon: Elektronisk (PDF) Innholdsfortegnelse Norges Skøyteforbunds Årbok 2015-2017 2/150 Innkalling til ordinært ting for Norges Skøyteforbund Det innkalles herved til Forbundsting på Quality Hotel Edvard Grieg (Sandsliåsen 50, 5254 Bergen) på Sandsli like utenfor Bergen, 9. – 11. juni 2017. Tingforhandlingene starter fredag 9. juni kl. 16.30. Forslag og saker som ønskes behandlet på Skøytetinget 2017, må være begrunnet og innsendt gjennom et lag eller en krets til forbundsstyret innen 9 mai 2017. Minimumskrav for at for at saker/lovforslag skal bli behandlet ifb med NSFs Ting, er at innmeldte saker/forslag inneholder henvisninger til aktuelle lover/regler og konkrete forslag til endret tekst/ordlyd. NSFs lover er her: https://skoyte.klubb.nif.no/dokumentarkiv/Documents/NSF%20lov%20revidert%20NIFs%20lovnorm %20Mai%202017.pdf Forslag/saker sendes elektronisk til Norges Skøyteforbund på epost: [email protected] Skøytetinget 2017 avholdes i henhold til § 14, 15, 16, 17 og 18 i Norges Skøyteforbunds lov. Dagsorden 1. Tingets åpning a) Minnetaler b) Åpningstale c) Hilsningstaler 2. Konstituering a) Godkjenning av innkalling til Tinget b) Godkjenning av fullmaktene c) Godkjenning av dagsorden d) Godkjenning av forretningsorden e) Valg av: - 2 dirigenter - sekretærer - 2 tillitsvalgte til å undertegne protokollen - reisefordelingskomité - tellekorps - Valg av redaksjonskomite på 3 medlemmer 3. Beretninger 4. Regnskap Norges Skøyteforbunds Årbok 2015-2017 3/150 a) Regnskap for perioden 1.1.2015 til 31.12.2015 b) Regnskap for perioden 1.1.2016 til 31.12.2016 5.
    [Show full text]
  • UEFA"Direct #153 (01.11.2015)
    WE CARE ABOUT FOOTBALL No. 153 | November 2015 IN THIS ISSUE Official publication of the EURO 2016: RENDEZ-VOUS Union of European Football Associations IN PARIS ON 12 DeceMBER 4 With just four final tournament places left to fill and the final Getty Images draw fast approaching, the teams in the starting blocks for / Chief editor: EURO 2016 are eager to know who they will be up against first Emmanuel Deconche when the ball starts rolling on 10 June. AFP Produced by: GraphicTouch CH-1110 Morges Printing: Artgraphic Cavin SA SOLIDARITY paYMENTS for clubS 6 CH-1422 Grandson A portion of the revenue from the UEFA Champions League Editorial deadline: is earmarked for the clubs – all 183 of them this season – that 4 November 2015 competed in qualifying for either of UEFA’s two flagship club competitions. Getty Images The views expressed in signed articles are not necessarily the official views of UEFA. The reproduction of articles published in UEFA·direct is authorised, provided the UNpreceDENTED ANTI-DOPING source is indicated. proGRAMME for EURO 2016 9 The UEFA Anti-Doping Panel met at UEFA headquarters in September to give the green light to UEFA’s most comprehensive anti-doping programme yet. UEFA EuropeaN football UNITED AGAINST raciSM 10 The FARE network’s annual action weeks in October prompted a new wave of No to Racism activities and events all over Europe, with UEFA matches played during that period giving ever greater Cover: prominence to the campaign. via Getty Images UEFA On matchday 3, Bayer 04 Leverkusen (Kevin Kampl in red and
    [Show full text]
  • Unit 10 Shock,Resuscitation Part A
    Vanderbilt University Medical Center Emergency General Surgery Service Surgical Residency Rotation and Curriculum UNIT 10SHOCK, RESUSCITATION, AND SURGICAL CRITICAL CARE PART A: SHOCK AND RESUSCITATION UNIT OBJECTIVES: 1. Demonstrate an understanding of the pathophysiology of shock and its categories. 2. Demonstrate an understanding of the mechanisms and pathophysiology of cardiopulmonary arrest. 3. Demonstrate the ability to manage the treatment of shock and cardiopulmonary arrest. COMPETENCY-BASED KNOWLEDGE OBJECTIVES: 1. Define the categories of shock based upon type, and explain the etiology and pathophysiology of each type of shock: a. Cardiogenic b. Hypovolemic c. Distributive (septic, anaphylactic, neurogenic, and adrenal insufficiency mediated) d. Obstructive (cardiac tamponade, tension pneumothorax, pulmonary embolus) 2. Summarize the clinical presentation and hemodynamic parameters associated with each type of shock. 3. Propose an algorithm for diagnosing and initiating treatment for each shock type. 4. Discuss the pathophysiology, including the mechanism of arrest, for each of the following situations: a. Acute myocardial infarction f. Substance abuse b. Acute dysrhythmia g. Hypothermia c. Congestive heart failure h. Acute stroke d. Pulmonary embolus i. Hemorrhagic shock e. Tension pneumothorax 5. Explain the indications for and the pharmacokinetics of each of the following drugs: a. Lidocaine g. Quinidine b. Bretylium h. Isoproterenol c. Digoxin i. Amiodarone d. Propanolol j. Dopamine e. Verapamil k. Dobutamine f. Pronestyl l. Adenosine (Adenocard®) 6. Summarize the indications and the appropriate techniques for cardioversion and defibrillation. Vanderbilt University Medical Center Emergency General Surgery Service Surgical Residency Rotation and Curriculum 7. Outline the signs and symptoms of acute airway obstruction and define the appropriate intervention in adult and pediatric patients.
    [Show full text]
  • 3 Sommaire / Inhaltsübersicht
    Sommaire / Inhaltsübersicht 1. Bericht des Rektors über das Akademische Jahr / Rapport du Recteur sur l’année universitaire ......................................................................... 7 1.1. Bericht ................................................................................................................................ 7 1.2. Die Universitätsgemeinschaft / La communauté universitaire ........................................ 71 1.2.1. Studierende / Etudiant-e-s ...............................................................................71 1.2.2. Wissenschaftliche MitarbeiterInnen / Collaborateurs et collaboratrices scientifiques .....................................................................................................72 1.2.3. Professorenschaft / Corps professoral . ............................................................ 72 1.3. Der Senat / Le Sénat ......................................................................................................... 73 1.4. Finanzen / Finances .......................................................................................................... 73 2. Rapports des Organes de l’Université / Berichte der Universitätsorgane .......................... 75 2.1. Rapports des commissions, instituts et service universitaires / Berichte der Universitätskommissionen, -institute und –dienste ......................................................... 75 2.1.1. Rekurskommission ..........................................................................................75 2.1.2.
    [Show full text]
  • Verksamhetsberättelse Med Årsredovisning 2018-2020 Innehåll
    Verksamhetsberättelse med årsredovisning 2018-2020 Innehåll 3 Ordförande har ordet 4 Verksamhet 4 Styrelsens berättelse för verksamhetsåren 2018-2020 5 Internationell verksamhet 2018-2019 7 Internationell verksamhet 2019-2020 10 Nationell verksamhet 2018-2019 11 Nationell verksamhet 2019-2020 12 Utbildningsverksamhet 2018-2019 14 Utbildningsverksamhet 2019-2020 15 Verksamhet för tekniska funktionärer 2018-2019 16 Verksamhet för tekniska funktionärer 2019-2020 17 Tävlingsverksamhet 2018-2019 19 Tävlingsverksamhet 2019-2020 23 Corona 24 Förbundsstyrelsen 2018-2020 25 Kommittéer och uppdrag 26 Årsredovisning 2018-2019 27 Förvaltningsberättelse 29 Resultaträkning 30 Balansräkning 31 Noter 35 Årsredovisning 2019-2020 36 Förvaltningsberättelse 40 Resultaträkning 41 Balansräkning 42 Noter 48 Skatesweden Events AB Årsredovisning 2019-2020 56 Representation 58 Stipendier 59 Tävlingsresultat 70 Erövrade teknikmärken 72 Verksamhetsinriktning 2020-2022 73 Statistik 2 Ordföranden har ordet glädjande beskedet att vi vann arrangemanget av VM i konståk- ning 2021. Helt enligt vår plan. Att lyfta konståkningen i Stockholm med EM, Synkro-VM och nu också VM bygger ett starkare förbund och lyfter konståkningen i hela Sverige. Under året införde vi Elitlicens som sedan följdes av Föreningslicens. Både viktiga och goda verktyg för att stödja verksamheten i våra föreningar. Efter utvärderingar ser vi att förbättringar måste göras och det arbetet pågår just nu. Säsongen 2019 - 2020 präglas också av att Förbundet har gått till botten med anmälningar om missförhållanden i ett antal föreningar. Styrelsen tog beslut om att genomföra en omfattande extern utredning. Resultatet visar tyvärr att det finns åkare som inte mår bra. Något som självklart är helt oacceptabelt. Ett barn som far illa är ett för mycket.
    [Show full text]
  • Complex Hypertension
    COMPLEX HYPERTENSION Anita Ralstin, FNP-BC Next Step Health Consultant, LLC Incidence Of Hypertension ¨ About 70 million American adults have high blood pressure. About 33% of the population ¨ Only 52% have BP under control. ¨ Nearly a third of US adults have prehypertension. ¨ Hypertension costs $46 billion a year. (healthcare services, medications, missed work) From CDC Blood Pressure Facts 2015 What is Hypertension? ¨ JNC 7 (1997) definitions Stages Systolic Diastolic Prehypertension 102-129 OR 80-89 High BP Stage 1 140-159 OR 90-99 High BP Stage 2 160 or higher OR 100 or higher ¨ JNC 7 Goal BP = <140/90 ¨ JNC 8: did not define classification ¤ Patients 60 and +, start Rx when BP > 150/90* ¤ Patient < 60, start Rx when BP > 140/80 From National Heart, Lung Blood Institute SPRINT Study ¨ NIH supported study ¨ 9000+ subjects ¨ With at least one risk factor for CV disease ¨ Preliminary findings--- ¨ Adults 50 and older with HBP, targeting a SBP <120 reduced rates of CV events by 25%; reduced risk of death by 27% compared to a target of SBP 140. National Heart, Lung and Blood Institute Complex/Resistant Hypertension ¨ Resistant hypertension is defined as blood pressure that remains above goal despite concurrent use of three antihypertensive agents of different classes, one of which should be a diuretic. ¨ Patients whose blood pressure is controlled with four or more medications are considered to have resistant hypertension. Complex Hypertension ¨ BP above goal- 140/90 most patients. 130/80 diabetics or renal disease. ¨ Confirmed on at least two occasions with appropriate size cuff. ¨ Adherence to appropriate 3 drug regiment including a diuretic.
    [Show full text]
  • Initial Approach to Hypertension in the Hemodynamics Unit: Review Article
    REVIEW ARTICLE Initial approach to hypertension in the hemodynamics unit: review article Abordagem inicial da hipertensão arterial sistêmica em unidade de hemodinâmica: artigo de revisão Gustavo Teixeira Fulton Schimit1, José Manoel da Silva Silvestre2, Wander Eduardo Sardinha2, Eduardo Durante Ramires2, Domingos de Morais Filho2, Guilon Otávio Santos Tenório1, Fernando Barbosa Trevisan1 Abstract Correct identification and early management of hypertensive disorders should be a part of the therapeutic repertoire of every professional working in hemodynamics units. Based on recent publications, this study aims to propose a practical approach to the identification and early management of these disorders in this type of service. Keywords: hypertension; blood pressure; therapeutics; antihypertensive agents. Resumo O reconhecimento correto e manejo inicial das síndromes hipertensivas devem fazer parte do arsenal terapêutico de todo profissional que trabalhe em unidade de hemodinâmica. Este trabalho tem por objetivo, baseado em publicações recentes, propor uma abordagem prática para identificação e manejo inicial destes agravos nessa unidade. Palavras-chave: hipertensão; pressão arterial; terapêutica; anti-hipertensivos. 1Hospital Universitário Regional do Norte do Paraná, Londrina, PR, Brazil. 2Departamento de Clínica Cirúrgica, Universidade Estadual de Londrina – UEL, Londrina, PR, Brazil. Conflict of interest: No conflicts of interest declared concerning the publication of this article. Submitted on: 01.21.12. Accepted on: 03.25.13. The study was carried out at Hospital Universitário da Universidade Estadual de Londrina – UEL, Londrina, PR, Brazil. J Vasc Bras. 2013 Jun; 12(2):133-138 133 Hypertension in the hemodynamics unit INTRODUCTION been objectively adopted for the definition of normal Constant technical advances in the profession, blood pressure, and increases of 20/10 mm Hg above as well as in materials and new technologies, have this level double the risk of cardiovascular diseases11.
    [Show full text]
  • Ekaterina ALEXANDROVSKAYA AUS Harley WINDSOR
    PAIRS Date of birth: 01.01.2000 Ekaterina ALEXANDROVSKAYA Place of birth: Moscow RUS Height: 154 cm AUS Home town: Moscow RUS Profession: high school student Hobbies: country vacation, reading Start sk. / Club: 2004 / Sydney FSC Internet / Social Media contact (couple): www.facebook.com/Katia2016Harley/ Former Partners Date of birth: 22.10.1996 Harley WINDSOR Place of birth: Penrith Height: 185 cm AUS Home town: Sydney Profession: athlete Hobbies: Start sk. / Club: 2005 / Sydney FSC Internet / Social Media contact (couple): www.facebook.com/Katia2016Harley/ Former Partners Coach: A. and G. Pachin, A. Hekalo, N. Mozer Choreographer: A. Pachin, D. OBrien, I. Tchiniaev Former Coach: Practice low season: 19 h / week Moscow/RUS Practice high season: 25 h / week Sydney, Moscow/RUS Music Short Program / Short Dance as of season 2016/2017 Skyfall (James Bond soundtrack) by Adele Music Free Skating / Free Dance as of season 2016/2017 W.E. (soundtrack) by Abel Korzeniowski Personal Best Total Score 163.98 17.03.2017 ISU World Junior Championships 2017 Personal Best Score Short Program 59.82 15.03.2017 ISU World Junior Championships 2017 Personal Best Score Free Skating 104.16 17.03.2017 ISU World Junior Championships 2017 09/10 10/11 11/12 12/13 13/14 14/15 15/16 16/17 Olympic Games World Champ. European Champ. Four Continents 11. World Juniors 1. National Champ. 1.S S=Senior; J=Junior; N=Novice International Competition Year Place Internation Competition Year Place ISU JGP Czech Skate 2016 Ostrava 2016 8. J ISU CS Finlandia Trophy 2016 Espoo 2016 6.
    [Show full text]
  • 3 Blood Pressure and Its Measurement
    Chapter 3 / Blood Pressure and Its Measurement 49 3 Blood Pressure and Its Measurement CONTENTS PHYSIOLOGY OF BLOOD FLOW AND BLOOD PRESSURE PHYSIOLOGY OF BLOOD PRESSURE MEASUREMENT POINTS TO REMEMBER WHEN MEASURING BLOOD PRESSURE FACTORS THAT AFFECT BLOOD PRESSURE READINGS INTERPRETATION OF BLOOD PRESSURE MEASUREMENTS USE OF BLOOD PRESSURE MEASUREMENT IN SPECIAL CLINICAL SITUATIONS REFERENCES PHYSIOLOGY OF BLOOD FLOW AND BLOOD PRESSURE The purpose of the arterial system is to provide oxygenated blood to the tissues by converting the intermittent cardiac output into a continuous capillary flow and this is achieved by the structural organization of the arterial system. The blood flow in a vessel is basically determined by two factors: 1. The pressure difference between the two ends of the vessel, which provides the driving force for the flow 2. The impediment to flow, which is essentially the vascular resistance This can be expressed by the following formula: 6P Q = R where Q is the flow, 6P is the pressure difference, and R is the resistance. The pressure head in the aorta and the large arteries is provided by the pumping action of the left ventricle ejecting blood with each systole. The arterial pressure peaks in systole and tends to fall during diastole. Briefly, the peak systolic pressure achieved is determined by (see Chapter 2): 1. The momentum of ejection (the stroke volume, the velocity of ejection, which in turn are related to the contractility of the ventricle and the afterload) 2. The distensibility of the proximal arterial system 3. The timing and amplitude of the reflected pressure wave When the arterial system is stiff, as in the elderly, for the same amount of stroke output, the peak systolic pressure achieved will be higher.
    [Show full text]